Piper Sandler Maintains Overweight on OptiNose, Lowers Price Target to $3
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Amsellem has maintained an Overweight rating on OptiNose (NASDAQ:OPTN) but lowered the price target from $4 to $3.
August 11, 2023 | 4:33 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler has maintained an Overweight rating on OptiNose but lowered the price target from $4 to $3.
The lowering of the price target by Piper Sandler from $4 to $3 indicates a potential decrease in the stock's value. However, the maintained Overweight rating suggests that the company is still expected to outperform the market, which could mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100